FinanceCryptocurrency
Moomoo Expands Crypto Trading to Texas with Direct Crypto Transfers
Moomoo, a subsidiary of Futu, has expanded its cryptocurrency trading services to Texas, now offering direct crypto deposits and withdrawals...
18 days ago
FinanceCryptocurrency
Sonnet BioTherapeutics Transforms into HYPE Cryptocurrency Treasury with $888 Million Deal
11 months agoUS
Sonnet BioTherapeutics (NASDAQ: SONN) is set to transform its business focus, pivoting from biotechnology to cryptocurrency through an $888 million business combination with Rorschach I LLC. This deal will create Hyperliquid Strategies Inc (HSI), poised to become the largest U.S.-based publicly listed company holding HYPE cryptocurrency in its treasury.
Key Insights
•
Strategic Shift: Sonnet BioTherapeutics is transitioning from biotech to a cryptocurrency treasury strategy focused on HYPE.
•
Financial Details: The deal involves $583 million in HYPE tokens (12.6 million tokens) and $305 million in gross cash.
•
Key Players: Notable investors include Paradigm, Galaxy Digital, and Pantera Capital. Bob Diamond will become Chairman, and David Schamis will be CEO of HSI.
•
Ownership Structure: Current Rorschach owners and new investors will own approximately 98.8% of HSI, while legacy SONN stockholders will retain 1.2%.
•
Timeline: The transaction is expected to close in the second half of 2025.
Why This Matters: This move provides a unique opportunity for investors seeking exposure to the HYPE token and the Hyperliquid ecosystem through a publicly traded vehicle. It also highlights the increasing convergence of traditional finance and the digital asset space.
In-Depth Analysis
Background
Sonnet BioTherapeutics, previously focused on oncology-related biotechnology, is undergoing a radical transformation. The company is entering a business combination with Rorschach I LLC to form Hyperliquid Strategies Inc (HSI), a cryptocurrency treasury company focused on accumulating and managing HYPE tokens.
Transaction Details
The deal involves Sonnet receiving $583 million in HYPE tokens (12.6 million tokens) and $305 million in gross cash, totaling $888 million. Key investors include Paradigm, Galaxy Digital, and Pantera Capital, signaling strong confidence in the new direction. Upon closing, Bob Diamond and David Schamis of Atlas Merchant Capital will assume leadership roles at HSI.
Impact on Shareholders
Existing Sonnet shareholders will experience significant dilution, retaining only 1.2% ownership in HSI. However, they will receive Contingent Value Rights (CVRs) related to Sonnet's existing biotech assets, which will continue as a wholly-owned subsidiary of HSI. The company will also continue the development of SON-1010, while divesting other assets.
About HYPE
HYPE is the native token of the Hyperliquid layer one blockchain, used in Hyperliquid's custom consensus algorithm, HyperBFT. As of July 6th, 2025, HYPE ranks as the 13th-largest cryptocurrency by market capitalization, according to Forbes.
How to Prepare
•
Monitor HYPE Performance: Keep an eye on the performance of HYPE as the deal progresses, as HSI's value will be closely tied to it.
•
Understand CVR Terms: If you are a current SONN shareholder, understand the terms and potential value of the Contingent Value Rights (CVRs) you will receive.
Who This Affects Most
•
Current SONN Shareholders: They will see a major shift in the company's business model and a significant dilution of their ownership.
•
Crypto Investors: Those seeking exposure to HYPE, especially institutional investors who find it difficult to access the token directly.
FAQs
•
Q: What is the value of the business combination between Sonnet BioTherapeutics (SONN) and Rorschach?
The business combination is valued at $888 million, comprising $583 million in HYPE tokens and $305 million in gross cash.
•
Q: How many HYPE tokens will Hyperliquid Strategies Inc hold after the merger?
HSI will hold approximately 12.6 million HYPE tokens, valued at $583 million based on the spot price at the time of the agreement.
•
Q: Who will lead Hyperliquid Strategies Inc (HSI) after the merger?
Bob Diamond, Co-founder and CEO of Atlas, will serve as Chairman of the Board, while David Schamis, CIO and Co-founder of Atlas, will be CEO.
•
Q: What percentage will current SONN shareholders own in the new company?
Legacy SONN stockholders, including PIPE and bridge investors, will own approximately 1.2% of the new company, while Rorschach owners and new investors will own 98.8%.
•
Q: When is the SONN business combination expected to close?
The business combination is expected to close in the second half of 2025, subject to stockholder approval and other customary closing conditions.
•
Q: What happens to Sonnet's biotech business after the merger?
Sonnet will operate as a wholly-owned subsidiary of HSI, continuing to focus on existing assets including SON-1010 development, while disposing of other assets. Shareholders will receive a CVR related to the biotech assets.
Key Takeaways
•
Sonnet BioTherapeutics is transforming into a cryptocurrency treasury company focused on HYPE.
•
The deal involves a significant investment from key players in the crypto space.
•
Existing SONN shareholders will experience dilution but receive CVRs for the biotech assets.
•
The transaction is expected to close in the second half of 2025.
•
This provides a new avenue for investors to gain exposure to the HYPE token.
Discussion
Do you think this trend of biotech companies pivoting to cryptocurrency is sustainable? Let us know in the comments!
Share this with others who need to stay ahead of this trend!
Related Articles
FinanceCryptocurrency
SoftBank Sells Circle Stock: Should You Still Buy?
SoftBank's recent sale of its Circle (CRCL) stock has raised eyebrows, but a closer look reveals a company with strong fundamentals and grow...
20 days ago
FinanceCryptocurrency
Ethereum Dencun Upgrade
The Ethereum Dencun upgrade marks a significant advancement in the Ethereum network, primarily aimed at reducing transaction costs on Layer-...
24 days ago
FinanceCryptocurrency
South Korean Crypto Shutdowns Freeze Millions in User Assets
Fifteen virtual asset service providers in South Korea have ceased operations, resulting in 22.114 billion won ($15.8 million) in unreturned...
about 1 month ago
⚠ Disclaimer: Yanuki provides article summaries and links for reference only. Yanuki does not endorse, verify, or guarantee the accuracy of third-party sources. Please review original sources and verify information independently. Managed by the Yanuki Data Engine. Full Disclaimer